top of page
Executive Spotlights

ONI Appoints Paul Scagnetti as CEO to Implement Next Chapter of Growth

Oxford, England & San Diego, CA, February 27, 2023 (Business Wire) -- ONI, the biotechnology company broadly enabling the ability to observe single molecules in living cells with its desktop Nanoimager microscopy platform, today announced that Paul Scagnetti has been appointed as the company's new CEO, effective February 27, 2023. Along with this leadership change, ONI will begin to implement a new strategy to accelerate commercial growth and expand its impact in research and discovery. Paul succeeds founding CEO, Bo Jing, who will remain with ONI as a key contributor in product development to help inspire ONI’s next innovations.

Read full article here.

Recent Posts

See All


Life Science Headlines
bottom of page